Skip to main content

United States News All stories

Every story in this section, newest first — page 293 of 373.

Grafa
Health

CVS revenue hits record $402B as Aetna turnaround offsets $7B in charges

CVS Health (NYSE:CVS) reported on Tuesday, February 10, 2026, that it has become the first pure-play healthcare company to surpass $400 billion in annual revenue, even as a series of heavy one-time charges masked the underlying strength of its Aetna and Caremark units.

Read more: CVS revenue hits record $402B as Aetna turnaround offsets $7B in charges
Grafa
Health

Zimmer Biomet beats estimates but cautious 2026 guidance weighs on shares

Zimmer Biomet Holdings (NYSE:ZBH) reported fourth-quarter results on Tuesday, February 10, 2026, that exceeded Wall Street expectations, though the medical device giant’s shares remained under pressure following a "cautious" outlook for the coming fiscal year.

Read more: Zimmer Biomet beats estimates but cautious 2026 guidance weighs on shares
Grafa
Technology

Sequans posts record loss on Bitcoin impairment while signaling 2026 turnaround

Sequans Communications (NYSE: SQNS) released unaudited fourth-quarter and full-year 2025 financial results on Tuesday, February 10, 2026, revealing a complex balance sheet shaped by its pioneering—and volatile—Bitcoin treasury strategy.

Read more: Sequans posts record loss on Bitcoin impairment while signaling 2026 turnaround
Grafa
Technology

Meta wins procedural victory as EU high court revives WhatsApp fine appeal

The European Court of Justice (ECJ) ruled on Tuesday, February 10, 2026, that WhatsApp Ireland’s legal challenge against the European Data Protection Board (EDPB) is admissible, breathing new life into a five-year battle over a €225 million ($268 million) privacy fine.

Read more: Meta wins procedural victory as EU high court revives WhatsApp fine appeal
Grafa

Honda operating profit plunges 61% as U.S. tariffs and EV slowdown hit results

Honda Motor (NYSE:HMC) reported on Tuesday, February 10, 2026, that its fiscal third-quarter operating profit tumbled 61.4% as the company navigates a perfect storm of U.S. trade tariffs and a costly pivot in its electric vehicle strategy.

Read more: Honda operating profit plunges 61% as U.S. tariffs and EV slowdown hit results
Grafa
Oil and Gas

BP suspends buybacks as $4B impairment triggers heavy quarterly loss

BP (NYSE:BP) reported a substantial fourth-quarter net loss of $3.42 billion on Tuesday, as the British energy major took a massive $4.3 billion post-tax impairment charge primarily linked to its "transition businesses" in the gas and low-carbon energy segments.

Read more: BP suspends buybacks as $4B impairment triggers heavy quarterly loss
Grafa
Health

AstraZeneca misses estimates as higher R&D spending offsets oncology growth

AstraZeneca (NASDAQ:AZN) reported fourth-quarter and full-year 2025 results on Tuesday that failed to meet Wall Street’s expectations, as a surge in operating costs for its expanding drug pipeline dampened the impact of double-digit sales growth in its oncology division.

Read more: AstraZeneca misses estimates as higher R&D spending offsets oncology growth